sales@intentmarketresearch.com
+1 463-583-2713
As per Intent Market Research, the High Throughput Screening Market was valued at USD 24.4 billion in 2023 and will surpass USD 51.0 billion by 2030; growing at a CAGR of 11.1% during 2024 - 2030.
The report focuses on estimating the current market potential in terms of the total addressable market for all the segments, sub-segments, and regions. In the process, all the high-growth and upcoming technologies were identified and analyzed to measure their impact on the current and future market. The report also identifies the key stakeholders, their business gaps, and their purchasing behavior. This information is essential for developing effective marketing strategies and creating products or services that meet the needs of the target market. The report also covers a detailed analysis of the competitive landscape which includes major players, their recent developments, growth strategies, product benchmarking, and manufacturing operations among others. Also, brief insights on start-up ecosystem and emerging companies is also included as part of this report.
The report will help you answer some of the most critical questions in the High Throughput Screening Market. A few of them are as follows:
Report Features |
Description |
Market Size (2023-e) |
USD 24.4 billion |
Forecasted Value (2030) |
USD 51.0 billion |
CAGR (2024-2030) |
11.1% |
Base Year for Estimation |
2023 |
Historic Year |
2022 |
Forecast Period |
2024-2030 |
Report Coverage |
Market Forecast, Market Dynamics, Competitive Landscape, Recent Developments |
Segments Covered |
High Throughput Screening Market By Product & Service (Software, Instrument, Consumable, Service), By Technology (Cell-based Assays, Label-free, Lab-on-a-Chip), By Application (Biochemical Screening, Drug Discovery, Life Sciences Research), By End-Use (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic & Research Institutes) |
Regional Analysis |
North America (US, Canada, Mexico), Europe (Germany, France, UK, Spain, Italy & Rest of Europe), Asia Pacific (China, Japan, South Korea, India, and rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, & Rest of Latin America), Middle East & Africa (Saudi Arabia, South Africa, Turkey, United Arab Emirates, & Rest of MEA) |
Customization Scope |
Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements |
1.Introduction |
|
1.1.Market Definition |
|
1.2.Scope of the Study |
|
1.3.Research Assumptions |
|
1.4.Study Limitations |
|
2.Research Methodology |
|
2.1.Research Approach |
|
2.1.1. Top-Down Method |
|
2.1.2. Bottom-Up Method |
|
2.1.3. Factor Impact Analysis |
|
2.2.Insights & Data Collection Process |
|
2.2.1. Secondary Research |
|
2.2.2. Primary Research |
|
2.3.Data Mining Process |
|
2.3.1. Data Analysis |
|
2.3.2. Data Validation and Revalidation |
|
2.3.3. Data Triangulation |
|
3.Executive Summary |
|
3.1.Major Markets & Segments |
|
3.2.Highest Growing Regions and Respective Countries |
|
3.3.Impact of Growth Drivers & Inhibitors |
|
3.4.Regulatory Overview by Country |
|
4.High Throughput Screening Market, by Product & Service (Market Size & Forecast: USD Billion, 2024 – 2030) |
|
4.1.Consumables |
|
4.1.1. Laboratory Equipment |
|
4.1.2. Reagents & Assay Kits |
|
4.2.Instruments |
|
4.2.1. Detection Systems |
|
4.2.2. Liquid Handling Systems |
|
4.2.3. Other Instruments |
|
4.3.Software |
|
4.4.Services |
|
5.High Throughput Screening Market, by Technology (Market Size & Forecast: USD Billion, 2024 – 2030) |
|
5.1. Cell-based Assays |
|
5.2. Label-free Technology |
|
5.3. Lab-on-a-Chip Technology (LOC) |
|
6.High Throughput Screening Market, by Application (Market Size & Forecast: USD Billion, 2024 – 2030) |
|
6.1. Biochemical Screening |
|
6.2. Drug Discovery |
|
6.3. Life Sciences Research |
|
6.4. Other Applications |
|
7. High Throughput Screening Market, by End-Use (Market Size & Forecast: USD Billion, 2024 – 2030) |
|
|
|
|
|
|
|
|
|
8.Regional Analysis |
|
8.1. Regional Overview |
|
8.2. North America |
|
8.2.1. Regional Trends & Growth Drivers |
|
8.2.2. Barriers & Challenges |
|
8.2.3. Opportunities |
|
8.2.4. Factor Impact Analysis |
|
8.2.5. Technology Trends |
|
8.2.6. North America High Throughput Screening Market, by Product & Service |
|
8.2.7. North America High Throughput Screening Market, by Technology |
|
8.2.8. North America High Throughput Screening Market, by Application |
|
*Similar segmentation will be provided at each regional level |
|
8.3.By Country |
|
8.3.1. US |
|
8.3.1.1. US High Throughput Screening Market, by Product & Service |
|
8.3.1.2. US High Throughput Screening Market, by Technology |
|
8.3.1.3. US High Throughput Screening Market, by Application |
|
8.3.2. Canada |
|
8.3.3. Mexico |
|
*Similar segmentation will be provided at each country level |
|
8.4.Europe |
|
8.5.APAC |
|
8.6.Latin America |
|
8.7.Middle East & Africa |
|
9.Competitive Landscape |
|
9.1.Overview of the Key Players |
|
9.2.Competitive Ecosystem |
|
9.2.1. Platform Manufacturers |
|
9.2.2. Subsystem Manufacturers |
|
9.2.3. Service Providers |
|
9.2.4.Software Providers |
|
9.3. Company Share Analysis |
|
9.4. Company Benchmarking Matrix |
|
9.4.1. Strategic Overview |
|
9.4.2. Product Innovations |
|
9.5. Start-up Ecosystem |
|
9.6. Strategic Competitive Insights/ Customer Imperatives |
|
9.7. ESG Matrix/ Sustainability Matrix |
|
9.8. Manufacturing Network |
|
9.8.1. Locations |
|
9.8.2. Supply Chain and Logistics |
|
9.8.3. Product Flexibility/Customization |
|
9.8.4. Digital Transformation and Connectivity |
|
9.8.5. Environmental and Regulatory Compliance |
|
9.9. Technology Readiness Level Matrix |
|
9.10. Technology Maturity Curve |
|
9.11. Buying Criteria |
|
10.Company Profiles |
|
10.1. Agilent Technologies |
|
10.1.1. Company Overview |
|
10.1.2. Company Financials |
|
10.1.3. Product/Service Portfolio |
|
10.1.4. Recent Developments |
|
10.1.5. IMR Analysis |
|
*Similar information will be provided for other companies |
|
10.2.Thermo Fisher Scientific |
|
10.3.Merck |
|
10.4.Danaher Corporation |
|
10.5.PerkinElmer |
|
10.6.Agilent |
|
10.7.Bio-Rad Laboratories |
|
10.8.Lonza |
|
10.9.Corning |
|
10.10.Eurofins Scientific |
|
11.Appendix |
A comprehensive market research approach was employed to gather and analyze data on the High Throughput Screening Market. In the process, the analysis was also done to estimate the parent market and relevant adjacencies to major the impact of them on the high throughput screening Market. The research methodology encompassed both secondary and primary research techniques, ensuring the accuracy and credibility of the findings.
Secondary research involved a thorough review of pertinent industry reports, journals, articles, and publications. Additionally, annual reports, press releases, and investor presentations of industry players were scrutinized to gain insights into their market positioning and strategies.
Primary research involved conducting in-depth interviews with industry experts, stakeholders, and market participants across the high throughput screening ecosystem. The primary research objectives included:
A combination of top-down and bottom-up approaches was utilized to estimate the overall size of the high throughput screening market. These methods were also employed to estimate the size of various subsegments within the market. The market size estimation methodology encompassed the following steps:
To ensure the accuracy and reliability of the market size estimates, data triangulation was implemented. This involved cross-referencing data from various sources, including demand and supply side factors, market trends, and expert opinions. Additionally, top-down and bottom-up approaches were employed to validate the market size estimates.